Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti‐IgE immune complexes
- 1 July 1998
- journal article
- research article
- Published by Wiley in Parasite Immunology
- Vol. 20 (7) , 311-317
- https://doi.org/10.1046/j.1365-3024.1998.00146.x
Abstract
Infestations of humans with the parasitic nematode T. canis are common in both developing and industrialized countries. Most infestations induce a clinically inapparent course of infection, however, severe clinical manifestations, i.e. visceral larva migrans (VLM) or ocular larva migrans (OLM) syndromes are observed. To find an explanation for the different courses of toxocarosis we examined several serological parameters: the expression of (i) specific IgE (Immunoblot, IB), (ii) specific IgG subclasses (IgG1–4, ELISA) and the formation of (iii) IgE/anti‐IgE immune complexes. Serum samples were obtained from persons with symptomatic (VLM, OLM) and asymptomatic course (AS) of the infestation. As antigen, T. canis excretory/secretory (TES) antigen from L3 larvae was used. Reactivity of IgE against SDS‐PAGE separated TES antigens was marginally higher in toxocarosis patients (35%) than in asymptomatics (24%), but without statistical significance. TES‐specific IgG (1–4), predominant subclass in all three groups was IgG1, followed by IgG2, IgG4 and IgG3. Subclasses IgG1, 2, 4 showed significant differences between patients with VLM associated symptoms and asymptomatic persons (P < 0.001) but not between patients with OLM associated symptoms and asymptomatics. Significantly elevated levels of IgE/anti‐IgE immune complexes were detected in sera of patients with symptomatic course of the disease, both VLM and OLM (P < 0.001). Whereas specific IgG may act via antibody dependent cell‐mediated cytotoxicity mechanisms, IgE/anti‐IgE immune complexes might possibly participate in VLM and OLM by inducing type III hypersensitivity.Keywords
This publication has 28 references indexed in Scilit:
- Inhibition of human IgE synthesis by anti‐IgE antibodies requires divalent recognitionEuropean Journal of Immunology, 1994
- Die klinische Bedeutung von Anti-IgE-Antikörpern für die Behandlung der allergischen RhinopathieLaryngo-Rhino-Otologie, 1990
- Prevalence and Functional Role of Anti-IgE Autoantibodies in Urticarial SyndromesJournal of Investigative Dermatology, 1988
- Clinical Features of Covert ToxocariasisScandinavian Journal of Infectious Diseases, 1987
- IgG anti‐IgE in circulating immune complexes in the hyper‐IgE syndromeClinical and Experimental Allergy, 1986
- Dépistage de la maladie de Chagas par immunoenzymologieComparaison de l'ELISA avec l'immunofluorescence et l'hémagglutination indirecte chez 976 donneurs de sangRevue Française de Transfusion et Immuno-hématologie, 1985
- Effector and Regulatory Mechanisms in Immunity to Schistosomes: A Heuristic ViewAnnual Review of Immunology, 1985
- IgG-containing and IgE-containing circulating immune complexes in patients with asthma and rhinitisJournal of Allergy and Clinical Immunology, 1984
- HUMAN TOXOCARA INFECTION IN WEST OF SCOTLANDThe Lancet, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970